Temporal trends in the diagnosis of neuromyelitis optica spectrum disorder in US claims databases from 2001-2017

被引：0
|
作者：
Engmann, N. J. [1 ]
Wu, N. [1 ]
Sheinson, D. [1 ]
Costantino, C. [2 ]
Sidiropoulos, P. [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] F Hoffman La Roche Ltd, Basel, Switzerland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1130
引用
收藏
页码：612 / 612
页数：1
相关论文
共 50 条
  • [1] Temporal Trends in the Diagnosis of Neuromyelitis Optica Spectrum Disorder in US Insurance Claims Databases From 2001 to 2017
    Exuzides, A.
    Engmann, N.
    Wu, N.
    Sidiropoulos, P.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 109 - 110
  • [2] Identifying Patients With Neuromyelitis Optica Spectrum Disorder in US Insurance Claims Databases From 2001 to 2017
    Exuzides, A.
    Ning, W.
    Sheinson, D.
    Costantino, C.
    Sidiropoulos, P.
    Engmann, N.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 104 - 105
  • [3] Identification and temporal trends of patients with neuromyelitis optica spectrum disorder in a US insurance claims database
    Exuzides, Alex
    Wu, Ning
    Sheinson, Daniel
    Flores Avile, Carlos
    Costantino, Cristina
    Sidiropoulos, Paris
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 581 - 588
  • [4] Identifying patients with neuromyelitis optica spectrum disorder in US insurance claims databases
    Wu, N.
    Sheinson, D.
    Costantino, C.
    Engmann, N. J.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 168 - 169
  • [5] The costs of care from a US claims database in patients with neuromyelitis optica spectrum disorder
    Exuzides, Alex
    Sheinson, Daniel
    Sidiropoulos, Paris
    Gholizadeh, Shervin
    Magrini, Fabio
    Surinach, Andy
    Cook, Lawrence
    Meyer, Craig S.
    Yeaman, Michael R.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 427
  • [6] Estimating the cost of illness for patients with neuromyelitis optica spectrum disorder from us commercial claims
    Exuzides, A.
    Sheinson, D.
    Sidiropoulos, P.
    Gholizadeh, S.
    Surinach, A.
    Cook, L.
    Meyer, C.
    Yeaman, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 457 - 458
  • [7] Cost of neuromyelitis optica spectrum disorder in us clinical practice
    Kielhorn, A.
    Royston, M.
    Weycker, D.
    Shaff, M.
    Houde, L.
    Tanvir, I.
    Levy, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 454 - 454
  • [8] From neuromyelitis optica to neuromyelitis optica spectrum disorder: from clinical syndrome to diagnistic classification
    Aktas, Orhan
    Kuempfel, Tania
    NERVENARZT, 2021, 92 (04): : 307 - 316
  • [9] NEUROMYELITIS OPTICA SPECTRUM DISORDER: A DECADE TO GET A DIAGNOSIS THAT FITS
    Janarthen, Vahini
    Warner, Graham
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (12):
  • [10] Biotinidase deficiency in differential diagnosis of neuromyelitis optica spectrum disorder
    Bilge, Nuray
    Yevgi, Recep
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 44
12345